Berapakah harga Sigilon Therapeutics, Inc. (SGTX)

Harga Sigilon Therapeutics, Inc. (SGTX) adalah $22.47

Apakah topi pasaran Sigilon Therapeutics, Inc. (SGTX)

Cap pasaran Sigilon Therapeutics, Inc. (SGTX) adalah $49.76M

Sigilon Therapeutics, Inc. (SGTX) EPS

Cambridge, Massachusetts-based Sigilon Therapeutics, Inc., established in 2015, functions as a clinical-stage biotechnology firm dedicated to creating lasting solutions for patients grappling with chronic health conditions. Its primary investigational therapy, SIG-001, is currently undergoing Phase I/II clinical assessment to prevent bleeding episodes in individuals suffering from moderate to severe Hemophilia A. The company's research pipeline also encompasses SIG-005, designed to address the non-neurological symptoms associated with mucopolysaccharidosis type 1; SIG-007, engineered to ensure a continuous and sustained delivery of functional enzymes sufficient to generate clinical improvements and halt the advancement of Fabry disease; and SIG-002, an initiative focused on replacing islet cells for the treatment of Type 1 Diabetes. Furthermore, Sigilon Therapeutics holds a collaborative research and licensing agreement with Eli Lilly and Company for the advancement and market release of SLTx product candidates targeting Type 1 Diabetes. Originally known as Sigilon, Inc., the company officially adopted its current name in June 2017.

Tahun	EPS	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

EPS

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	EPS	Perbezaan EPS	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$2.98	-	AU
Lonza Group AG LONN.SW	-	-	CH
Moderna, Inc. MRNA.US	$-7.98	-	US

Syarikat

EPS

Perbezaan EPS

Negara